Initiation and intensification of insulin therapy in patients with type 2 diabetes mellitus: a budget impact analysis

Initiation and intensification of insulin therapy in patients with type 2 diabetes mellitus: a budget impact analysis

To date, several options for starting and intensifying insulin therapy in patients with type 2 diabetes mellitus (T2DM) have been proposed. Meta-analyzes of the recent results shows that, with adequate use, all these regimens have the similar efficacy and safety; therefore, when choosing a therapeut...

Full description

Saved in:

Bibliographic Details
Main Authors:	E. V. Biryukova, V. I. Ignat’eva
Format:	Article
Language:	Russian
Published:	IRBIS LLC 2017-11-01
Series:	Фармакоэкономика
Subjects:	type 2 diabetes mellitus t2dm initiation of insulin therapy intensification of insulin therapy ready-made mixture of insulin analogues budget impact analysis
Online Access:	https://www.pharmacoeconomics.ru/jour/article/view/203
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Individual stepwise intensification of insulin analogue therapy in type 2 diabetes mellitus
by: Alexander Sergeevich Ametov, et al.
Published: (2012-12-01)

When basal insulin is not enough: successful strategies for insulin intensification in patients with type 2 diabetes mellitus
by: Elena V. Buryukova, et al.
Published: (2017-12-01)

Effects of metformin on body weight in patients with type 2 diabetes mellitus,receiving insulin analogue treatment
by: Tatiana Ivanovna Romantsova, et al.
Published: (2013-03-01)

A review of insulin lispro for the treatment of patients with type 2 diabetes mellitus
by: Marina V. Shestakova, et al.
Published: (2016-07-01)

Modern basal insulins: an ongoing story or the start of a new era?
by: Ivan Ivanovich Dedov
Published: (2015-12-01)

Insulin degludec: a new basal insulin analogue with an ultra-long duration of action. Safety and efficacy in Russian patients with diabetes
by: Marina Vladimirovna Shestakova, et al.
Published: (2015-12-01)

On the centenary of the insulin discovery
by: I. I. Dedov, et al.
Published: (2021-02-01)

Intensification of glucose-lowering treatment in patients with diabetes mellitus type 2 on insulin therapy: Perspectives of dapagliflozin
by: Olga Yuryevna Sukhareva, et al.
Published: (2016-01-01)

Effective and safe control of glycemia with insulin Apidra - the recipe for success of type 2 diabetes prophylaxis
by: Elena Valer'evna Biryukova
Published: (2011-12-01)

Overcoming marked insulin resistance in a patient with type 2 diabetes mellitus by means of insulin pumptherapy
by: Ekaterina Viktorovna Artemova, et al.
Published: (2012-09-01)

Evaluation of Clinical Efficacy of Smart Insulin for Diabetes Management: A Systematic Review
by: Chintan Doshi
Published: (2025-05-01)

Availability and Pharmacoeconomics of Insulin Therapy in Countries with the Largest Number of Diabetics
by: S. V. Ponomarenko
Published: (2019-10-01)

The first and only combination of basal and prandial insulin analogs degludec and aspart: the position of Russian endocrinologists
by: M. V. Shestakova, et al.
Published: (2021-07-01)

ANALISIS EFEKTIVITAS BIAYA PENGGUNAAN TERAPI INSULIN DAN INSULIN KOMBINASI PADA PASIEN DIABETES MELLITUS TIPE II RAWAT JALAN DI RSUP SANGLAH
by: I Made Agus Sunadi Putra, et al.
Published: (2017-09-01)

Modern approach to the evaluation of the pharmacokinetics and pharmacodynamics of biosimilar recombinant human insulin and insulin analogues in I phase clinical study
by: Irina A. Proskurina, et al.
Published: (2016-07-01)

Efficacy and safety of premixed versus basal‐bolus regimens as intensification of insulin therapy in patients with type 2 diabetes mellitus: A systematic review and meta‐analysis of randomized clinical trials
by: Mohsen Dehghani, et al.
Published: (2025-05-01)

Features of insulin therapy in combination of long-term type 1 diabetes mellitus and metabolic syndrome
by: M. D. Samsonova, et al.
Published: (2024-11-01)

Abnormal insulin metabolism and decreased levels of mindfulness in type 2 diabetes mellitus
by: Xue Zhang, et al.
Published: (2025-01-01)

Psychological insulin resistance among patients with diabetes mellitus in Botswana
by: Engemadzo Bitsang, et al.
Published: (2025-04-01)

Modern approach to basal-bolus therapy with glargine and glulisine insulin analoguesin various age groups
by: Natalya Nikitichna Volevodz, et al.
Published: (2013-03-01)

Lypohypertrophy in patients receiving insulin therapy: state of the art
by: Natalya Ivanovna Volkova, et al.
Published: (2011-06-01)

Circulating prosaposin and ependymin-related protein 1 levels are correlated with insulin resistance in type 2 diabetic patients
by: Xin Ji, et al.
Published: (2025-06-01)

Comparative efficacy assessment for various insulin regimens in patients with type 2 diabetes mellitus, ischaemic heart disease and frequent hypoglycemic events
by: Vladimir Ivanovich Kudinov, et al.
Published: (2012-06-01)

Basal insulin therapy in patients with type 2 diabetes mellitus and poor control of glycemia by oral hypoglycemic agents: results of direct comparative study of insulin analogs Lantus and Levemir
by: Alsu Gafurovna Zalevskaya, et al.
Published: (2010-06-01)

Pharmacoepidemiological analysis of type 1 diabetes mellitus insulin therapy (According to the Moscow segment of the State Register of Diabetes Mellitus)
by: M. B. Antsiferov, et al.
Published: (2023-11-01)

Tissue-specific and whole-body insulin sensitivity by integrated imaging and hyperinsulinemic euglycemic clamp: A repeatability study in people with T2DM and overweight/obesity
by: Iina Laitinen, et al.
Published: (2025-08-01)

Comparative analysis of glycemic control effectiveness and microvascular complications in patients with type 1 diabetes mellitus, treated with genetically engineered human insulin or human insulin analogues: A 10-year retrospective observational study
by: Marina V. Shestakova, et al.
Published: (2016-11-01)

Understanding the link between type 2 diabetes mellitus and Parkinson’s disease: role of brain insulin resistance
by: Theodora Ntetsika, et al.
Published: (2025-11-01)

Fetuin-A – Alpha2-Heremans-Schmid Glycoprotein: From Structure to a Novel Marker of Chronic Diseases Part 2. Fetuin-A – A Marker of Insulin Resistance and Related Chronic Diseases
by: Regina Komsa-Penkova, et al.
Published: (2018-06-01)

The Comparison and Correlation of Serum Levels of Insulin and Na+/ K+ Atpase In Type 2 Diabetes Mellitus (T2DM) And Non-Diabetes Mellitus Individuals
by: Karar Kazem Mohammed, et al.
Published: (2022-09-01)

Pharmacoeconomic analysis of clinical efficiency of combined metformin (Siofor) - insulin therapy in patients with type 2 diabetes mellitus
by: I Yu Demidova, et al.
Published: (2009-06-01)

A1chieve Program in Russian Federation: a multicenter prospective observational study of insulin analogue treatment efficiency and safety in daily management of patients with type 2 diabetes mellitus, who startand intensify insulin treatment having never received it before
by: Marina Vladimirovna Shestakova
Published: (2012-03-01)

Differences in the insulin counterregulatory hormones between obese and nonobese male patients with type 2 diabetes mellitus
by: Rong Huang, et al.
Published: (2025-04-01)

Insulin pump therapy of type 1 diabetes mellitus in children and adolescents in the Moscow region
by: Elena Efimovna Petryaykina, et al.
Published: (2009-09-01)

Intermittent fasting in the treatment of type 2 diabetes
by: Damian Dyńka, et al.
Published: (2025-08-01)

Once‐Weekly Insulin Versus Once‐Daily Insulin for Type 1 Diabetes Treatment: A Systematic Review and Meta‐Analysis of Randomised Controlled Trials
by: Obieda Altobaishat, et al.
Published: (2025-05-01)

Insulin therapy during pregnancy in women with type 1 diabetes
by: V V Potin, et al.
Published: (2009-03-01)

Risk of heart failure in patients with type 2 diabetes receiving insulin therapy: a meta-analysis of observational studies
by: S. V. Mironova, et al.
Published: (2023-04-01)

Pump insulin therapy in pediatric practice
by: O. V. Stotikova, et al.
Published: (2021-06-01)

Priority areas in management of diabetes mellitus type 1 & 2 (following 47th EASD Annual Meeting)
by: Ivona Renata Yarek-Martynova, et al.
Published: (2011-12-01)